669 related articles for article (PubMed ID: 34019444)
1. [CME Dermatology 23: Hidradenitis suppurativa].
Dahmen RA; Lautenschlager S
Praxis (Bern 1994); 2021; 110(7):363-372. PubMed ID: 34019444
[TBL] [Abstract][Full Text] [Related]
2. [CME Dermatology 23/Answers: Hidradenitis suppurativa].
Dahmen RA; Lautenschlager S
Praxis (Bern 1994); 2021 Jun; 110(8):471-472. PubMed ID: 34107755
[TBL] [Abstract][Full Text] [Related]
3. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
4. [Hidradenitis suppurativa - symptoms, diagnostics, and therapy].
Arenbergerová M; Dahmen RA; Arenberger P
Cas Lek Cesk; 2017; 156(3):127-132. PubMed ID: 28722455
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
[TBL] [Abstract][Full Text] [Related]
6. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.
Zouboulis CC; Bechara FG; Fritz K; Goebeler M; Hetzer FH; Just E; Kirsten N; Kokolakis G; Kurzen H; Nikolakis G; Pinter A; Podda M; Rosinski K; Schneider-Burrus S; Taube KM; Volz T; Winkler T; Kristandt A; Presser D; Zouboulis VA
J Dtsch Dermatol Ges; 2024 Jun; 22(6):868-889. PubMed ID: 38770982
[TBL] [Abstract][Full Text] [Related]
7. [Hidradenitis suppurativa].
Tolaas E; Knudsen CW; Sviland L; Tønseth KA
Tidsskr Nor Laegeforen; 2009 May; 129(10):992-6. PubMed ID: 19448752
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.
Zouboulis CC
Expert Rev Clin Immunol; 2016 Oct; 12(10):1015-26. PubMed ID: 27531618
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa.
Danby FW; Margesson LJ
Dermatol Clin; 2010 Oct; 28(4):779-93. PubMed ID: 20883920
[TBL] [Abstract][Full Text] [Related]
10. Hidradenitis Suppurativa: Rapid Evidence Review.
Wipperman J; Bragg DA; Litzner B
Am Fam Physician; 2019 Nov; 100(9):562-569. PubMed ID: 31674740
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa-Possibilities and Limitations.
Świerczewska Z; Lewandowski M; Surowiecka A; Barańska-Rybak W
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077114
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
[TBL] [Abstract][Full Text] [Related]
13. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
[TBL] [Abstract][Full Text] [Related]
14. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab.
Caposiena Caro RD; Cannizzaro MV; Tartaglia C; Bianchi L
Clin Exp Dermatol; 2020 Jun; 45(4):438-444. PubMed ID: 31630436
[TBL] [Abstract][Full Text] [Related]
15. [Acne inversa (hidradenitis suppurativa)].
Iesalnieks I; Dornseifer U
Chirurg; 2020 Apr; 91(4):293-300. PubMed ID: 31915870
[TBL] [Abstract][Full Text] [Related]
16. Secukinumab in the treatment of hidradenitis suppurativa.
Snyder CL; Gibson RS; Porter ML; Kimball AB
Immunotherapy; 2023 Dec; 15(17):1449-1457. PubMed ID: 37840286
[TBL] [Abstract][Full Text] [Related]
17. A gene dysfunction module reveals the underlying pathogenesis of hidradenitis suppurativa: An update.
Li X; Jiang L; Huang Y; Ren Z; Liang X; Wang P
Australas J Dermatol; 2020 Feb; 61(1):e10-e14. PubMed ID: 31266094
[TBL] [Abstract][Full Text] [Related]
18. [What's new in the treatment of suppurative hidradenitis in 2018 ?].
Giet G; Lebas E; Libon F; Dezfoulian B; Nikkels AF
Rev Med Liege; 2018 Sep; 73(9):468-473. PubMed ID: 30188033
[TBL] [Abstract][Full Text] [Related]
19. Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study.
Zouboulis CC; Okun MM; Prens EP; Gniadecki R; Foley PA; Lynde C; Weisman J; Gu Y; Williams DA; Jemec GBE
J Am Acad Dermatol; 2019 Jan; 80(1):60-69.e2. PubMed ID: 29860040
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary approach for hidradenitis suppurativa patients.
Veraldi S; Guanziroli E; Benzecry V; Nazzaro G
G Ital Dermatol Venereol; 2018 Jun; 153(3 Suppl 2):18-19. PubMed ID: 30468376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
